These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Janus kinases to jakinibs: from basic insights to clinical practice. Gadina M; Le MT; Schwartz DM; Silvennoinen O; Nakayamada S; Yamaoka K; O'Shea JJ Rheumatology (Oxford); 2019 Feb; 58(Suppl 1):i4-i16. PubMed ID: 30806710 [TBL] [Abstract][Full Text] [Related]
25. Controlling inflammation: contemporary treatments for autoinflammatory diseases and syndromes. Sterba G; Sterba Y Dermatol Clin; 2013 Jul; 31(3):507-11. PubMed ID: 23827252 [TBL] [Abstract][Full Text] [Related]
26. Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype. Clarke SLN; Robertson L; Rice GI; Seabra L; Hilliard TN; Crow YJ; Ramanan AV Pediatr Rheumatol Online J; 2020 May; 18(1):37. PubMed ID: 32398023 [TBL] [Abstract][Full Text] [Related]
27. Successful canakinumab treatment identifies IL-1β as a pivotal mediator in Schnitzler syndrome. de Koning HD; Schalkwijk J; van der Meer JW; Simon A J Allergy Clin Immunol; 2011 Dec; 128(6):1352-4. PubMed ID: 21704363 [No Abstract] [Full Text] [Related]
28. Autoinflammatory Disorders: A Review and Update on Pathogenesis and Treatment. Havnaer A; Han G Am J Clin Dermatol; 2019 Aug; 20(4):539-564. PubMed ID: 30997665 [TBL] [Abstract][Full Text] [Related]
29. Biological and Clinical Changes in a Pediatric Series Treated with Off-Label JAK Inhibitors. Pin A; Tesser A; Pastore S; Moressa V; Valencic E; Arbo A; Maestro A; Tommasini A; Taddio A Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092242 [TBL] [Abstract][Full Text] [Related]
30. [Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Best practice with JAK inhibitors.]. Yamaoka K Clin Calcium; 2018; 28(5):678-685. PubMed ID: 29731464 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of JAK/STAT signaling in rheumatologic disorders: The expanding spectrum. El Jammal T; Gerfaud-Valentin M; Sève P; Jamilloux Y Joint Bone Spine; 2020 Mar; 87(2):119-129. PubMed ID: 31521793 [TBL] [Abstract][Full Text] [Related]
34. JAK inhibitors in chronic plaque psoriasis: What is known so far. Plachouri KM; Georgiou S Drugs Today (Barc); 2020 Feb; 56(2):151-163. PubMed ID: 32163530 [TBL] [Abstract][Full Text] [Related]
36. Regulating against the dysregulation: new treatment options in autoinflammation. Kallinich T Semin Immunopathol; 2015 Jul; 37(4):429-37. PubMed ID: 26059720 [TBL] [Abstract][Full Text] [Related]
37. The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature. Crowley EL; Fine SC; Katipunan KK; Gooderham MJ J Cutan Med Surg; 2019; 23(3):289-297. PubMed ID: 30688081 [TBL] [Abstract][Full Text] [Related]